Artiva Biotherapeutics In... (ARTV)
NASDAQ: ARTV
· Real-Time Price · USD
2.78
-0.01 (-0.36%)
At close: Aug 20, 2025, 1:26 PM
Artiva Biotherapeutics Income Statement
Financials in USD. Fiscal
year is
undefined.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 |
Revenue | n/a | n/a | n/a | n/a | n/a | 251K | 2.35M | 26.66M | n/a | 989K |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | n/a | n/a | n/a | n/a | 251K | 2.35M | 26.66M | n/a | 989K |
Operating Income | -22.81M | -22.17M | -18.27M | -18.34M | -16.19M | -14.49M | -11.97M | 10.81M | -11.82M | -17.69M |
Interest Income | 1.56M | 1.86M | 2.18M | 1.85M | n/a | 650K | 583K | 418K | n/a | 1.02M |
Pretax Income | -21.25M | -20.31M | -9.21M | -17.47M | -14.54M | -13.96M | -10.9M | 11.28M | -15.86M | -16.72M |
Net Income | -21.25M | -20.31M | -9.21M | -17.47M | -14.54M | -13.96M | -10.97M | 11.28M | -15.86M | -16.72M |
Selling & General & Admin | 4.95M | 5.12M | 4.95M | 4.81M | 3.86M | 3.59M | 3.17M | 2.78M | 4.06M | 3.91M |
Research & Development | 17.86M | 17.05M | 13.32M | 13.52M | 12.33M | 11.16M | 11.15M | 13.06M | 11.26M | 14.77M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | 147K | n/a | n/a | -31K | -53K |
Operating Expenses | 22.81M | 22.17M | 18.27M | 18.34M | 16.19M | 14.74M | 14.32M | 15.85M | 15.32M | 18.68M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | n/a | 22.17M | 18.27M | 18.34M | 16.19M | 14.74M | 14.32M | 15.85M | 15.32M | 18.68M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | 72K | n/a | n/a | n/a |
Shares Outstanding (Basic) | 24.38M | 24.34M | 11.26M | 18.9M | 23.28M | 17.58M | 20.43M | 9.36M | 17.58M | 17.58M |
Shares Outstanding (Diluted) | 24.38M | 24.34M | 11.26M | 18.9M | 23.28M | 17.58M | 20.43M | 9.36M | 17.58M | 17.58M |
EPS (Basic) | -0.87 | -0.83 | -0.82 | -0.92 | -0.62 | -0.79 | -0.54 | 1.20 | -0.9 | -0.95 |
EPS (Diluted) | -0.87 | -0.83 | -0.82 | -0.92 | -0.62 | -0.79 | -0.54 | 1.20 | -0.9 | -0.95 |
EBITDA | -22.81M | -21.54M | -17.65M | -17.71M | -15.59M | -13.9M | -11.38M | 11.37M | -14.78M | -17.11M |
EBIT | n/a | -22.17M | -18.27M | -18.34M | -16.19M | -14.49M | -11.97M | 10.81M | -15.32M | -17.69M |
Depreciation & Amortization | n/a | 628K | 614K | 627K | 603K | 587K | 594K | 556K | 538K | 578K |